FDA approves IV formulation of drug for CINVOctober 27, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated Issues
CHMP recommends new formulation of pegaspargaseOctober 15, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Midostaurin approved to treat AML, SM in EuropeSeptember 21, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
CHMP recommends approval of generic imatinibSeptember 18, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
CHMP advocates refusal of application for SM drugSeptember 18, 2017Leukemia, Myelodysplasia, TransplantationPharmacy
Application for pegfilgrastim biosimilar withdrawnSeptember 17, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
CHMP recommends approval of nilotinib for kidsSeptember 16, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
FDA approves drug to treat relapsed FLSeptember 15, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas